As multispecifics is hailed the fourth wave of drug discovery, with more clinical candidates and commercial success than ever before, the 13^th World Bispecific Summit arrives at a pivotal time to deliver the holy grail of precision oncology.

This industry-leading conference is the largest global gathering of bi-, tri- and multispecific drug discovery and development scientists, from molecule design to manufacturing. Benchmark and update your platform and clinical progress; advance mechanistic diversity, reduced toxicity and higher target affinity; and link manufacturability to novel formats of the next generation.

Network with and gather intelligence from over 150 chemistry, discovery, and clinical drug hunters with expertise in protein engineering, clinical pharmacodynamic, prognostic biomarkers, process development and manufacturability.

Be there in person to consolidate, catch up, and realize the potential of multi-specifics in multi-modal disease!